BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 5 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 5 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 5 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 6 hours ago Celanese Corporation Shares Dropping 5.5% 6 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 6 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 6 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 6 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 5 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 5 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 5 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 6 hours ago Celanese Corporation Shares Dropping 5.5% 6 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 6 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 6 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 6 hours ago
ADVERTISEMENT
Breaking News

Celanese Corporation Shares Jump 5.2%

Celanese Corporation surged 5.2% Monday to $66.41 after dual analyst upgrades from Wells Fargo and UBS lifted price targets by an average of 8.6%. The chemi...

April 13, 2026 2 min read

Celanese Corporation surged 5.2% Monday to $66.41 after dual analyst upgrades from Wells Fargo and UBS lifted price targets by an average of 8.6%. The chemi...

CE
Price
$66.41
Change
+5.2%
Volume
491,272

Celanese Corporation (NYSE: CE) surged 5.2% Monday to $66.41 after recent dual analyst upgrades that lifted price targets by an average of 8.6%. The chemical manufacturer’s shares rallied on 491,272 shares of volume as Wall Street analysts turned more bullish on the stock’s near-term prospects.

The synchronized analyst actions suggest a shift in sentiment toward the chemicals sector. With a market capitalization of $7.4 billion, Celanese represents a significant player in the industry, and recent upgrades indicate analysts may be warming to the company’s competitive positioning or near-term catalysts. The average target increase of 8.6% reflects material changes to Wall Street’s valuation models for the stock.

Trading volume reflected heightened investor interest in the analyst moves. At 491,272 shares, Monday’s activity captured attention as traders repositioned following the dual upgrades. The price action suggests investors are taking the analyst optimism seriously.

The upgrade cycle comes as Celanese navigates a complex environment for chemical manufacturers. The magnitude of the target increases suggests analysts see improving fundamentals or valuation support at current levels.

What to Watch: Investors should monitor whether additional analysts revise their Celanese outlooks higher, and whether the stock can sustain momentum toward the new $70 average price target. Any commentary from the company on demand trends or margin dynamics could provide insight into what’s driving the analyst optimism.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT